FDA Approves Ocular Implant for Vision-Threatening MacTel

(MedPage Today) — The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia (MacTel) type 2, Neurotech Pharmaceuticals announced on Thursday.
A rare, progressive neurodegenerative…

Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/114553

Author :

Publish date : 2025-03-07 22:02:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

FDA Approves Ocular Implant for Vision-Threatening MacTel

After Years of Decline, Breast Cancer Mortality Rates No Longer Falling for Some

DOGE Fired These CDC, NIH Workers. Now They’re Speaking Out.

Related Posts

Rite of Passage or Road to Early Liver Damage?

The Partial Heart Transplant Because Kids Grow, Valves Don’t

When to Consider Cannabinoid Hyperemesis Syndrome in T1D

Disabled transport access a “national embarrassment”, MPs warn

Clot-Busting Ultrasound Gives Carotid Endarterectomy a Step Up

Dark energy is not what we thought – and that may transform the cosmos

Rite of Passage or Road to Early Liver Damage?

The Partial Heart Transplant Because Kids Grow, Valves Don’t

When to Consider Cannabinoid Hyperemesis Syndrome in T1D

Disabled transport access a “national embarrassment”, MPs warn

Clot-Busting Ultrasound Gives Carotid Endarterectomy a Step Up

Dark energy is not what we thought – and that may transform the cosmos

Active Surveillance May Have a Role in Esophageal Cancer

End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?

Categories

Archives